A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer-Reference-Cited by-同舟云学术

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer

Published:2009-11-26 Issue:3 Volume:119 Page:643-651
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

McCaig Fiona M.,Renshaw Lorna,Williams Linda,Young Oliver,Murray Juliette,Macaskill Elizabeth J.,McHugh Mary,Hannon Rosemary,Dixon J. Michael

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-009-0646-0.pdf

Reference24 articles.

1. Howell A, Cuzick J, Baum M, ATAC Trialists’ Group et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62

2. Thurlimann B, Keshaviah A, Coates AS, The Breast International Group (BIG) 1–98 Collaborative Group et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747–2757

3. Osborne CK (1999) Aromatase inhibitors in relation to other forms of endocrine therapy for breast cancer. Endocr Relat Cancer 6:271–276

4. Grey AB, Stapleton JP, Evans MC et al (1995) The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women. Am J Med 99:636–641

5. Marttunen MB, Hietanen P, Tiitinen A et al (1998) Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients. J Clin Endocrinol Metab 83:1158–1162

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol;Trials;2024-09-02

2. Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer;JAMA Network Open;2024-01-10

3. Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors;Journal of Bone and Mineral Metabolism;2023-05-29

4. Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy;JAMA Network Open;2019-09-27

5. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability;Annales de biologie clinique;2018-07